Access to GLP-1 medications associated with a lower risk of colorectal cancer in people with type 2 diabetes: JAMA.

Published Date: 11 Dec 2023

USA: Glucagon-like peptide 1 (GLP-1) was found to be more effective in reducing the risk of colorectal cancer (CRC) in a nationwide cohort study.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast cancer prevention: How nurse practitioners and physician assistants can help

2.

FDA Expands Durvalumab Label to Operable Lung Cancer

3.

ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death

4.

Mapping lifelong chronic health risks for childhood cancer survivors

5.

Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot